-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
REGENERX BIOPHARMACEUTICALS INC quarterly/annual Income Tax Expense (Benefit) history and change rate from 2012 to Q1 2023.
- REGENERX BIOPHARMACEUTICALS INC Income Tax Expense (Benefit) for the quarter ending 31 Mar 2023 was $0.000.
- REGENERX BIOPHARMACEUTICALS INC Income Tax Expense (Benefit) for the twelve months ending 31 Mar 2023 was $0.000.
- REGENERX BIOPHARMACEUTICALS INC annual Income Tax Expense (Benefit) for 2022 was $0.000.
- REGENERX BIOPHARMACEUTICALS INC annual Income Tax Expense (Benefit) for 2021 was $0.000.
- REGENERX BIOPHARMACEUTICALS INC annual Income Tax Expense (Benefit) for 2020 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)